SecSonar.com

Medifast, Inc. (MED)

Medifast, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Medifast, Inc. (MED) is a Personal Products & Services company based in US with a market capitalization of $144M. Revenue declined 36.0% year-over-year and the company generated $1.2M in free cash flow. This page tracks MED's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 504 employees · IPO Dec 30, 1993

Valuation

Valuation & price

$12.48 · as of May 17, 2026 · -18.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.72

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.21$12.37$9.53Jul 25Dec 25Jul 26Jul 7, 25$14.64Jul 9, 25$15.15Jul 11, 25$14.40Jul 15, 25$13.69Jul 17, 25$13.44Jul 21, 25$13.79Jul 23, 25$15.21Jul 25, 25$14.90Jul 29, 25$14.32Jul 31, 25$13.77Aug 4, 25$13.51Aug 6, 25$12.96Aug 11, 25$12.83Aug 13, 25$13.70Aug 15, 25$13.19Aug 19, 25$14.15Aug 21, 25$13.57Aug 25, 25$14.09Aug 27, 25$14.26Aug 29, 25$14.03Sep 3, 25$13.96Sep 5, 25$13.55Sep 9, 25$13.80Sep 11, 25$13.92Sep 16, 25$14.36Sep 18, 25$14.57Sep 22, 25$14.32Sep 24, 25$13.83Sep 26, 25$13.71Sep 30, 25$13.67Oct 2, 25$13.67Oct 6, 25$13.95Oct 8, 25$14.02Oct 10, 25$13.27Oct 14, 25$13.27Oct 16, 25$12.86Oct 21, 25$12.87Oct 23, 25$12.48Oct 27, 25$12.72Oct 29, 25$12.18Oct 31, 25$12.02Nov 4, 25$11.98Nov 6, 25$11.80Nov 10, 25$11.79Nov 12, 25$11.63Nov 14, 25$11.38Nov 18, 25$11.18Nov 20, 25$10.42Nov 25, 25$10.91Nov 28, 25$10.97Dec 2, 25$10.99Dec 4, 25$10.86Dec 8, 25$11.36Dec 10, 25$11.66Dec 12, 25$12.36Dec 16, 25$12.03Dec 18, 25$12.03Dec 22, 25$11.33Dec 24, 25$11.28Dec 29, 25$10.54Jan 2, 26$10.40Jan 6, 26$10.83Jan 8, 26$11.03Jan 12, 26$11.69Jan 14, 26$11.68Jan 16, 26$11.82Jan 21, 26$11.80Jan 23, 26$12.05Jan 27, 26$11.46Jan 29, 26$11.15Feb 2, 26$11.50Feb 4, 26$11.14Feb 9, 26$11.30Feb 11, 26$10.85Feb 13, 26$10.77Feb 18, 26$10.71Feb 20, 26$10.63Feb 24, 26$10.48Feb 26, 26$10.43Mar 2, 26$10.44Mar 4, 26$10.71Mar 6, 26$10.77Mar 10, 26$10.73Mar 12, 26$9.53Mar 17, 26$10.05Mar 19, 26$10.07Mar 23, 26$10.10Mar 25, 26$9.59Mar 27, 26$9.75Mar 31, 26$10.19Apr 2, 26$10.36Apr 7, 26$10.20Apr 9, 26$10.21Apr 13, 26$10.63Apr 15, 26$10.85Apr 17, 26$10.96Apr 22, 26$10.95Apr 24, 26$11.15Apr 28, 26$10.81Apr 30, 26$10.87May 4, 26$10.63May 6, 26$12.69May 8, 26$12.59May 12, 26$12.57May 14, 26$12.59May 18, 26$12.45May 20, 26$12.60May 22, 26$12.59May 28, 26$13.15Jun 1, 26$12.70Jun 3, 26$12.24Jun 5, 26$12.10Jun 9, 26$12.18Jun 11, 26$11.92Jun 15, 26$11.94Jun 17, 26$11.25Jun 22, 26$11.02Jun 24, 26$10.36Jun 26, 26$10.51Jul 2, 26$11.00
$9.5352-week range$15.22
Loading valuation history…

Fundamentals

Key fundamentals

$144M

Market cap

-36.0%

Revenue growth (YoY)

71.3%

Gross margin

$1.2M

Free cash flow (USD)

-$150.5M

Net debt

Net cash position

0.5%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Consumer Cyclical

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$274.5MFY 2017$301.6MFY 2018$501.0MFY 2019$713.7MFY 2020$934.8MFY 2021$1.5BFY 2022$1.6BFY 2023$1.1BFY 2024$602.5MFY 2025$385.8M
$274.5M$385.8M

Free cash flow by year

2016 → 2025

FY 2016$22.5MFY 2017$40.0MFY 2018$55.9MFY 2019$74.2MFY 2020$139.3MFY 2021$60.3MFY 2022$177.9MFY 2023$141.2MFY 2024$17.0MFY 2025$1.2M
$22.5M$1.2M

Gross margin by year

2021 → 2025

FY 202173.9%FY 202271.3%FY 202372.4%FY 202473.8%FY 202571.3%
73.9%71.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 4, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEmployee Separation AgreementJun 1, 2026Filing
  • 8-K eventShare Incentive Plan AmendedMay 26, 2026Filing
  • Insider buyInsider Buy $63KSCHLACKMAN SCOTT · Director · $63KMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing
  • Quarterly report10-Q FiledMay 4, 2026Filing

Questions

Frequently asked questions

What is Medifast, Inc.'s market cap?

Medifast, Inc. (MED) has a market capitalization of $144M.

What is MED's P/E ratio?

A meaningful P/E ratio is not available for MED — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MED's price-to-book (P/B) ratio?

MED trades at 0.72 times book value per share.

Are insiders buying MED stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Medifast, Inc. in the last 90 days.

Same arena

Related companies in Personal Products & Services

WW

WW International, Inc.

$171.1M

RGS

Regis Corporation

$70.6M

XWEL

XWELL, Inc.

$7.8M

MRM

MEDIROM Healthcare Technologies Inc.

$6.1M

EJH

E-Home Household Service Holdings Limited

$5M

BYAH

Park Ha Biological Technology Co., Ltd. Ordinary Shares

$853.6K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.